Bio -X Diagnostics
ActiveSummary
Bio -X Diagnostics has been active since 1990 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.6m and a net result of €56,097. Equity remains stable across the filed financial years (±0.9% per year). Its solvency ranks better than 76% of 6,081 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Directors
Not every act has been read: a resignation may still be missing
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| BioChek International BVfrom an act |
|
| FINALAB SASfrom an act |
|
| HOLDING MAESTROfrom an act |
|
| Béatrice BLANCHARD |
|
Owners and capital
Owners
1 ownerChain of control
- HOLDING MAESTRO
- Bio -X Diagnostics
Highest known parent: HOLDING MAESTRO. The sources do not say who stands above it.
Owners 1
- HOLDING MAESTROparent51.02%
According to the annual accounts to 31-08-2025 of Bio -X Diagnostics and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.